Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HYDROXYZINE PAMOATE USP, with a corresponding US DMF Number 38535.
Remarkably, this DMF maintains an Active status since its submission on July 03, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 07, 2023, and payment made on July 27, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II